InvestorsObserver
×
News Home

Do Analysts Agree Tuesday on Neurobo Pharmaceuticals Inc (NRBO) Stock's Target Price?

Tuesday, March 02, 2021 10:22 AM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Agree Tuesday on Neurobo Pharmaceuticals Inc (NRBO) Stock's Target Price?

InvestorsObserver is giving Neurobo Pharmaceuticals Inc (NRBO) an Analyst Rating Rank of 78, meaning NRBO is ranked higher by analysts than 78% of stocks. The average price target for NRBO is $16 and analyst’s rate the stock as a Strong Buy

Overall Score - 5
Wall Street analysts are rating NRBO a Strong Buy today. Find out what this means to you and get the rest of the rankings on NRBO!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.

InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Neurobo Pharmaceuticals Inc Stock Today?

Neurobo Pharmaceuticals Inc (NRBO) stock has risen 8.08% while the S&P 500 has fallen -0.19% as of 10:18 AM on Tuesday, Mar 2. NRBO is higher by $0.35 from the previous closing price of $4.33 on volume of 215,831 shares. Over the past year the S&P 500 has gained 26.03% while NRBO has fallen -66.57%. NRBO lost -$2.77 per share the over the last 12 months.

Click Here to get the full report on Neurobo Pharmaceuticals Inc (NRBO) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App